Skip to content

Regulation of Endothelial Progenitor Cells by Short-Term Exercise

Regulation of Endothelial Progenitor Cells by Short-Term Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01169831
Acronym
EPC-Ex
Enrollment
60
Registered
2010-07-26
Start date
2011-07-31
Completion date
2024-07-31
Last updated
2024-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aging, Cardiovascular Disease, Exercise

Brief summary

Endothelial Progenitor Cells (EPCs) are circulating cells released from bone marrow which are important for maintaining cardiovascular health. The prevalence of cardiovascular disease in older adults is associated with reduced circulating EPC numbers. Studies have shown reduced EPC number and function in old vs. young individuals, and endurance exercise training increases EPC number and function in young adults. Oxidative stress adversely affects endothelial cells and preliminary evidence indicates that oxidative stress negatively affects EPC function. Conversely, regular exercise reduces markers of oxidative stress and may enhance EPC function in older adults. The investigators hypothesize that older endurance-trained athletes and matched sedentary individuals will have markedly divergent EPC function and that altering the physical activity levels of both groups will move them to intermediate points between these two extremes. The investigators also propose that the investigators can mimic the effect of exercise training on EPC function in cell culture by altering intracellular levels of a key enzyme and a signaling molecule which the investigators have shown to regulate EPC function with respect to exercise training in young individuals.

Interventions

OTHERExercise Training

2 weeks of daily aerobic exercise training

OTHERExercise Cessation

Stopping all exercise for 2 weeks

Sponsors

University of Maryland, Baltimore
CollaboratorOTHER
University of Maryland, College Park
CollaboratorOTHER
Baltimore VA Medical Center
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
50 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* 50-80 years of age, BMI = 18-35 kg/m2, non-smoking, women must be postmenopausal

Exclusion criteria

* history of cardiovascular/cerebrovascular disease, diabetes, cancer, renal, liver disease, HIV; uncontrolled hyperlipidemia/hypertension

Design outcomes

Primary

MeasureTime frame
Baseline Endothelial progenitor cell numberDay 1
Final Endothelial Progenitor Cell NumberDay 15

Secondary

MeasureTime frame
Baseline Endothelial ReactivityDay 1
Final Endothelial ReactivityDay 15

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026